Status:
COMPLETED
A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
Lead Sponsor:
AstraZeneca
Conditions:
Obesity
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
This is a long term extension to study 137OB-201 which is designed to examine the effect of pramlintide on body weight and its safety and tolerability in obese subjects.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subject has completed Protocol 137OB-201.
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT00189514
Start Date
September 1 2005
End Date
June 1 2007
Last Update
June 11 2015
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Chula Vista, California, United States
2
Research Site
San Diego, California, United States
3
Research Site
Walnut Creek, California, United States
4
Research Site
Miami, Florida, United States